Biohaven Pharmaceutical Holding Company Ltd.
http://biohavenpharma.com/
Already a Biomedtracker subscriber?
You have access to the full company record through your subscription
Want to become a subscriber?
Subscribers get more company details, updates, company financials and company products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Biohaven Pharmaceutical Holding Company Ltd.
Biohaven Pursues Best-In-Class Sales With Nurtec ODT’s Migraine Prevention Approval
CEO Vlad Coric said the customizable use of Nurtec ODT to stop and prevent migraine attacks is a differentiating factor that will help it go up against big pharma competitors.
ICER Will Explore Link Between Reasonable Drug Pricing And ‘Fair’ US Formulary Policies
Study will examine prior authorization and other access restrictions at 15 of the largest US commercial payers for a group of 27 drugs.
More Small Biotechs Are Launching Drugs On Their Own
Emerging biopharma companies developed and launched 40% of all new drugs that hit the market in the US in 2020, a significant increase from five years ago, according to IQVIA.
AbbVie’s Q1 Revenue Growth Outpaces Big Pharma Peers
Bouncing back from the pandemic more strongly than its peers, AbbVie sees 40% growth for Botox and Juvederm, a good launch for Ubrelvy and continued strength from its mainstays.
Company Information
- Industry
-
Pharmaceuticals
-
Drug Delivery
- Controlled Release
- Macromolecule
-
Drug Delivery
-
Biotechnology
- Large Molecule
- Other Names / Subsidiaries
-
- Portage Biotech Inc.
- Portage Glasgow Limited (PGL)
- BioShin
- Biohaven Pharmaceuticals, Inc.
- Kleo Pharmaceuticals Inc.